Table 2.

Age-adjusted odds ratios (OR) and 95% confidence intervals (95% CI) for PCa in AAM and EAM and combined.

Rs# and gene; minor allele and its frequency	Dominant model OR (CI); P value	Recessive model OR (CI); P value	Additive model OR (CI); P value
rs4612601; EPHB2 AA: 0.49 (G) EA: 0.45 (A)	AAM: 1.09 (0.63–1.9); 0.749	0.86 (0.46–1.61); 0.638	0.99 (0.69–1.41); 0.951
	EAM: 1.18 (0.67–2.10); 0.564	0.9 (0.52–1.56); 0.709	1.02 (0.73–1.43); 0.912
	All: 1.13 (0.76–1.69); 0.537	0.89 (0.59–1.34); 0.565	1.00 (0.79–1.28); 0.969
rs4263970; EPHB2 AA: 0.47 (T) EA: 0.45 (C)	AAM: 0.98 (0.57–1.68); 0.932	0.88 (0.44–1.75); 0.711	0.95 (0.66–1.38); 0.797
	EAM: 1.08 (0.61–1.9); 0.795	0.76 (0.44–1.33); 0.334	0.93 (0.66–1.30); 0.665
	All: 1.02 (0.69–1.5); 0.918	0.81 (0.53–1.25); 0.343	0.94 (0.73–1.21); 0.630
rs822396; ADIPOQ AA: 0.2 (G) EA: 0.15 (G)	AAM: 0.89 (0.52–1.52); 0.671	1.64 (0.37–7.21); 0.511	0.96 (0.6–1.54); 0.878
	EAM: 0.75 (0.44–1.27); 0.288	1.1 (0.29–4.09); 0.094	0.82 (0.53–1.29); 0.392
	All: 0.82 (0.56–1.19); 0.285	1.29 (0.49–3.48); 0.601	0.88 (0.64–1.22); 0.456
rs10993994; MSMB AA: 0.2 (C) EA: 0.34 (T)	AAM: 0.82 (0.48–1.4); 0.472	1.04 (0.51–2.10); 0.919	0.92 (0.63–1.33); 0.657
	EAM: 1.04 (0.54–2.00); 0.899	0.61 (0.36–1.05); 0.077	0.81 (0.56–1.17); 0.258
	All: 0.9 (0.6–1.35); 0.611	0.75 (0.49–1.14); 0.177	0.87 (0.67–1.11); 0.261
rs1859962; HNF1B AA: 0.49 (G) EA: 0.2 (G)	AAM: 1.03 (0.61–1.74); 0.905	1.23 (0.54–2.81); 0.626	1.06 (0.72–1.56); 0.752
	EAM: 1.38 (0.77–2.45); 0.278	1.00 (0.57–1.76); 0.997	1.13 (0.79–1.6); 0.508
	All: 1.16 (0.8–1.69); 0.431	1.06 (0.67–1.69); 0.790	1.09 (0.85–1.4); 0.503
rs7501939; HNF1B AA: 0.48 (C) EA: 0.49 (T)	AAM: 1.34 (0.73–2.47); 0.343	2.42 (1.31–4.47); 0.0046	1.56 (1.08–2.27); 0.0193
	EAM: 0.82 (0.5–1.35); 0.439	1.13 (0.54–2.38); 0.742	0.93 (0.65–1.33); 0.692
	All: 0.99 (0.68–1.45); 0.981	1.76 (1.11–2.79); 0.0167	1.18 (0.92–1.52); 0.187
rs4430796; HNF1B AA: 0.34 (A) EA: 0.47 (A)	AAM: 0.57 (0.34–0.97); 0.0383	0.64 (0.29–1.42); 0.272	0.67 (0.46–0.99); 0.0431
	EAM: 1.27 (0.7–2.3); 0.439	0.98 (0.57–1.68); 0.946	1.07 (0.76–1.51); 0.689
	All: 0.81 (0.55–1.18); 0.273	0.86 (0.59–1.33); 0.500	0.87 (0.69–1.12); 0.279
rs2070874; IL4 AA: 0.45 (T) EA: 0.2 (T)	AAM: 0.94 (0.54–1.64); 0.824	1.45 (0.7–3.0); 0.314	1.08 (0.73–1.59); 0.700
	EAM: 0.65 (0.38–1.11); 0.115	0.92 (0.22–3.93); 0.916	0.72 (0.45–1.14); 0.161
	All: 0.82 (0.57–1.17); 0.275	1.32 (0.7–2.49); 0.386	0.94 (0.71–1.24); 0.649
rs627839; RNASEL AA: 0.46 (T) EA: 0.45 (T)	AAM: 1.2 (0.7–2.06); 0.511	1.63 (0.78–3.42); 0.192	1.24 (0.85–1.83); 0.252
	EAM: 0.86 (0.5–1.47); 0.571	0.99 (0.55–1.8); 0.986	0.94 (0.67–1.32); 0.710
	All: 1.01 (0.69–1.48); 0.952	1.21 (0.76–1.91); 0.427	1.06 (0.83–1.37); 0.632
rs4962416; CTBP2 AA: 0.23 (C) EA: 0.23 (C)	AAM: 0.9 (0.5–1.59); 0.709	5.65 (0.62–51.7); 0.125	1.05 (0.63–1.74); 0.861
	EAM: 1.69 (1.02–2.8); 0.0415	1.72 (0.68–4.31); 0.251	1.52 (1.02–2.26); 0.0384
	All: 1.28 (0.88–1.85); 0.198	2.12 (0.92–4.9); 0.0784	1.31 (0.97–1.78); 0.083

Bolded values denote statistically significant associations.